| __timestamp | Bristol-Myers Squibb Company | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 11947000000 | 19764000 |
| Thursday, January 1, 2015 | 12651000000 | 67426000 |
| Friday, January 1, 2016 | 14481000000 | 59752000 |
| Sunday, January 1, 2017 | 14710000000 | 65383000 |
| Monday, January 1, 2018 | 16014000000 | 70165000 |
| Tuesday, January 1, 2019 | 18067000000 | 44738000 |
| Wednesday, January 1, 2020 | 30745000000 | 39457000 |
| Friday, January 1, 2021 | 36445000000 | 97894000 |
| Saturday, January 1, 2022 | 36022000000 | 115306000 |
| Sunday, January 1, 2023 | 34313000000 | 453552000 |
| Monday, January 1, 2024 | 36351000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, Bristol-Myers Squibb Company and HUTCHMED (China) Limited present a fascinating study in contrasts. Over the past decade, Bristol-Myers Squibb has consistently demonstrated robust growth in gross profit, with a remarkable increase of nearly 187% from 2014 to 2023. This American pharmaceutical giant reached its peak in 2021, with gross profits soaring to over 36 billion dollars, showcasing its dominance in the industry.
Conversely, HUTCHMED, a key player in China's pharmaceutical sector, has shown a more modest trajectory. Despite a significant 2,194% increase in gross profit from 2014 to 2023, its figures remain a fraction of Bristol-Myers Squibb's. The year 2023 marked a high point for HUTCHMED, with gross profits reaching approximately 454 million dollars. This comparison highlights the diverse strategies and market dynamics influencing these two companies.
Who Generates Higher Gross Profit? Novartis AG or Bristol-Myers Squibb Company
Amgen Inc. and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Genmab A/S
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Viatris Inc.
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Bristol-Myers Squibb Company vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Key Insights on Gross Profit: Zoetis Inc. vs HUTCHMED (China) Limited
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Jazz Pharmaceuticals plc and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Grifols, S.A. vs HUTCHMED (China) Limited: A Gross Profit Performance Breakdown
Gross Profit Comparison: HUTCHMED (China) Limited and BioCryst Pharmaceuticals, Inc. Trends